RACB

Research Alliance Corp. II [RACB] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

RACB Stock Summary

In the News

RACB Financial details

Company Rating
-
Market Cap
0
Income
1.79M
Revenue
0
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
-
P/E
22.06
Forward P/E
-
PEG
-
P/S
-
P/B
0.29
P/C
-
P/FCF
-
Quick Ratio
5.94
Current Ratio
7.31
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
0.09
EPS next Y
-
EPS next Q
-
EPS this Y
-
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-
Revenue last 5Y
-
Revenue Q/Q
-
EPS Q/Q
355.07%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
1%
ROE
1%
ROC
-
Gross Margin
-
Oper. Margin
-
Profit Margin
-
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
9.64-10.45
52W High
+1.05%
52W Low
+12.28%
RSI
-
Rel Volume
-
Avg Volume
205.78K
Volume
5
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
0.45%
-
-
-
-
Beta
-
-
-
Volatility
0.02%, 0.02%
Prev Close
0%
Price
10.105
Change
0.45%

Something similar

Top by Market Cap
VTSAX
V
M&M.NS
FXAIX
MSF.DE
Same Sector
DODGX
SV
FSRXW
BUFIX
005945.KS
Check Those
GTPL.NS
AHACU
AMMX
STA-R.BK
290650.KQ
Similar Market Cap
GRNB
FLO.PA
PRVIX
VINIX
KAV.L

Company Profile

Financial Services Shell Companies

Research Alliance Corp. II does not have significant operations. The company intends to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. It identifies and acquires a business, focusing on the healthcare industry, such as in biotechnology sector. Research Alliance Corp. II was incorporated in 2020 and is based in Las Vegas, Nevada.